Fibrosis occurs when inflammation activates immune cells and fibroblasts to release collagen and cytokines that remodel and ...

Helex secures $3.5M seed funding to develop targeted non-viral gene therapies for kidney diseases with high unmet need.

Helex has raised $3.5m in an oversubscribed seed funding round spearheaded by pi Ventures to advance non-viral gene therapies ...

Chronic kidney disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste ...

AlloCAR70-NKT is an off-the-shelf immunotherapy using engineered immune cells to target kidney cancer without patient-specific customization. The therapy addresses challenges of traditional CAR-T ...

A new breakthrough in kidney transplant research may change how patients experience life after surgery. Instead of spending a lifetime on immune-suppressing drugs, some people are now living drug-free ...

Kidney failure, also known as end-stage renal disease (ESRD), occurs when kidneys lose their ability to filter waste and excess fluids from the blood effectively. This serious condition affects ...

Chronic kidney disease (CKD) affects more than 700 million people worldwide and is caused by genetic and environmental factors, as well as existing medical conditions. Known genetic risk factors for ...

Kidney cancer treatment has shifted towards active surveillance and minimally invasive surgeries, improving patient outcomes and preserving kidney function. Robotic surgical techniques, including ...